• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.39 número3

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.39 número3"

Copied!
8
0
0

Texto

(1)

w w w . r b h h . o r g

Revista

Brasileira

de

Hematologia

e

Hemoterapia

Brazilian

Journal

of

Hematology

and

Hemotherapy

Original

article

Blood/Injection

Fear

Scale:

Portuguese

version,

cultural

adaptation

and

psychometric

properties

in

a

large

sample

of

primary

health

care

users

Miriane

Lucindo

Zucoloto

,

Edson

Zangiacomi

Martinez

UniversidadedeSãoPaulo(USP),RibeirãoPreto,SP,Brazil

a

r

t

i

c

l

e

i

n

f

o

Articlehistory:

Received13February2017

Accepted23May2017

Availableonline27June2017

Keywords:

Fear Blood Injections Translating Psychometrics

a

b

s

t

r

a

c

t

Background:Blood/injectionphobiamayhaveimportantconsequencesforhealth.These

phobicindividuals,inmostcases,avoidcontactwithhealthsystems,postponeoravoid

medicalprocedures,avoidinvasivetreatmentsanddonotparticipateinhealth

promo-tionandearlydetectionofdiseaseinitiativessuchasvaccination,consultations,preventive

examsorblooddonation.Thus,specificandvalidatedinstrumentsarenecessarytoassess

thisvariable.In addition,a lack ofstudieson this thememaybeassociatedwith the

lowavailabilityofinstruments.ThisstudyaimedtoproposeaPortugueseversionofthe

Blood/InjectionFearScale(BIFS-P)andassessitspsychometricproperties.

Methods:Translationandback-translationwereperformed.Contentvaliditywasassessedin

twostepsbyapanelof20experts.Thepsychometricpropertieswereassessedinastratified

andrepresentativesampleofprimaryhealthcareserviceusersofRibeirãoPreto,

southeast-ernBrazil.Exploratoryandconfirmatoryfactoranalyseswereconductedusingapolychoric

correlationmatrix.

Results:Atotalof1054primaryhealthcareusersparticipated;79.7%werefemaleandthe

meanagewas40.6(standarddeviation=15.16)years.Accordingtotheexploratoryfactor

analysis,theitemscanbegroupedintothreeorfivefactorswithbestfitsbeingdetectedfor

thethree-andfive-factormodelsinconfirmatoryfactoranalysis.

Conclusion:Blood/InjectionFearScale(Portugueseversion)iseasytounderstandandapply

inthegeneralpopulation,showedadequatepsychometricproperties,andrepresentsan

alternativeintheassessmentofblood/injectionphobiaforfuturestudies.

©2017Associac¸ ˜aoBrasileiradeHematologia,HemoterapiaeTerapiaCelular.Published

byElsevierEditoraLtda.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense

(http://creativecommons.org/licenses/by-nc-nd/4.0/).

Correspondingauthorat:DepartmentofSocialMedicine,RibeirãoPretoMedicalSchool,UniversidadedeSãoPaulo(USP),Avenida

Bandeirantes,3900,14049-900MonteAlegre,RibeirãoPreto,SP,Brazil.

E-mailaddress:mirianezucoloto@gmail.com(M.L.Zucoloto).

http://dx.doi.org/10.1016/j.bjhh.2017.05.006

1516-8484/©2017Associac¸ ˜aoBrasileiradeHematologia,HemoterapiaeTerapiaCelular.PublishedbyElsevierEditoraLtda.Thisisan

(2)

Introduction

Bloodandinjectionphobiasarecharacterizedbyanextreme

aversionofseebloodorreceiveinjectionsorbesubjectedto

invasivemedicalprocedures.1

AccordingtoKoseandMandiracioglu,2amongthevarious

typesofspecificphobias,therearetwotypesofblood/injection

phobiadescribedinthescientificliteraturethatareclassified

according tothe presenceor absence of a vasovagal

reac-tion.Thevasovagalreaction,characterizedbyasuddeninitial

increaseinheartrateandbloodpressurefollowedbya

sud-dendrop,isadysphasiccardiovascularresponseelicitedin

the face ofthe exposureofthe individual to situations of

fear.Forthisreason,thevasovagalreactionisaccompanied

bysymptomssuchasdiscomfort,nausea,pallor,expressions

ofdisgust/loathing,andevenfainting,all ofwhicharevery

commonamongpatientswithbloodandinjectionphobias.2–4

Unlikeothertypesofspecificphobias,bloodandinjection

phobiasmayhaveimportantconsequencesforhealth.Inmost

cases,theseindividualsavoidcontactwithhealthsystems,

postponeoravoidmedicalprocedures,avoidinvasive

treat-mentsanddonotparticipateinhealthpromotionandearly

detectionofdiseaseinitiativessuchasvaccination,

consulta-tions,preventiveexamsorblooddonation.5,6

Inthefaceofthesedirectimplicationstothehealth,the

developmentandvalidationofspecificinstrumentsto

evalu-ateblood/injectionphobiaarenecessary.Someinstruments

wereproposed forthis investigationinthegeneral

popula-tion,suchastheBlood-InjectionSymptomScale(BISS)7and

theBlood/InjectionFearScale(BIFS).2

TheBIFSwasproposedbyKoseandMandiraciogluin20072

andconsistsof20itemsdividedintotwofactors,fearofblood

andfearofinjectionsandthesymptomsinvolved.Theoriginal

versionofthisscalewaspublishedinEnglishanduntilnow,

ithasnotbeentranslatedtootherlanguages.

Few studies have been conducted to investigate

blood/injection phobia in the Brazilian population.8,9 To

thebestofourknowledge,thereisonlyoneBrazilianstudy,

publishedbyD’ElReyandPaciniin2005;itinvestigatedthe

prevalenceofbloodandinjectionphobiasinarepresentative

sampleofthe generalpopulationofthe city ofSão Paulo.8

Amongtheresults,thecombinedprevalenceofbloodor

injec-tion phobiaswas 4.1%,withthis fear beingmorecommon

amongwomenandamongindividualswithlittleschooling.

Itisbelievedthatthelowavailabilityofinstrumentsthat

areappropriateandadaptedforuseinthegeneralpopulation

isassociatedwiththelownumberofepidemiologicalstudies

inBrazilonthistypeofphobia.Themajorityofstudiesinthe

areaperformedinBrazilreferstodiagnosticandtreatment

techniquesandare fromthe psychologyand/orpsychiatric

fields.10

Objectives

Inlightoftheforegoing,thisstudywasconductedtopresenta

PortugueseversionoftheBIFSandevaluateitspsychometric

propertiesinarepresentativesampleofprimaryhealthcare

usersinRibeirãoPreto,southeasternBrazil.

Methods

Instrumentcharacteristics

BIFS is composed of 20 items divided into two factors

accordingtotheoriginalproposal;thefirstis‘fearof

injec-tions’ (Items 1–12) and the second “fear of blood” (Items

13–20).2 Responses use a 5-point Likert scale (1=Strongly

agree;2=Agree; 3=Neither agreenordisagree;4=Disagree;

5=Stronglydisagree).2

Translation,backtranslationandculturaladaptation

Threebilingualtranslators,whosenativelanguageis

Brazil-ian Portuguese, performed the translation of the BIFS,

independently. The two researchers responsible for the

study, who are also bilingual, compared the three

trans-lated versions. Thus, the Portuguese version of BIFS was

defined.

The Portuguese version of the instrument was sent to

a translator fluent in Brazilian Portuguese whose native

languageisEnglishtoperformthebacktranslation.This

trans-latorwasnotawareofthecontentoftheoriginalscaleandwas

notinformedthatitwasaback-translation.Theback

trans-lationwas importanttoconfirmthatthe translationofthe

instrumentdidnotchangethemeaningoftheitemsaccording

totheoriginalproposal.

Afterthesesteps,thePortugueseversionoftheBIFS

(BIFS-P)wasobtainedandhaditspsychometricpropertiesevaluated

inthisstudy.

Contentvalidity

ToevaluatetheobjectivityandrelevanceoftheBIFS-P,the

con-tentofitsitems wasassessedindependentlybyapanelof

eightjudges,healthprofessionals,withexperiencein

hema-tologytransfusionmedicineand/orinprofessionalservicesin

primaryhealthcare.Judgeswereinformed aboutthe

objec-tivesof thestudy and were asked toclassify each itemof

the instrumentasadequate ornotadequate foruse inthe

targetpopulation.Suggestionsofmodificationsand

simplifi-cationofitemswere requestedinthesecases.Thecontent

validityindex(CVI)wascalculatedforeachitemconsidering

that IVC≤0.70 is indicative ofthe need ofa new

transla-tion (i.e., 30% or moreofthe judges classifiedthe item as

notadequate).11Accordingtothesuggestionsofthejudges,

someitemsweremodifiedaimingtosimplifyandimprovethe

understandingpriortotheapplicationoftheinstrumentinthe

targetpopulation.

In a second phase of the content analysis, a panel of

20 judges with experience in hematology and transfusion

medicine was invited to classify, also independently, each

item ofthe instrumentaccording toitsessentiality

(essen-tial,usefulbutnotessentialornotnecessary)toevaluate‘fear

ofbloodorinjections’.Thecontentvalidityratiowas

calcu-latedaccordingtotheproposalofLawshe.12Thesignificance

ofthedecisionwasinaccordancewiththeproposalofWilson

(3)

Trainingofinterviewers

Beforestartingdatacollection,thethreeinterviewers

respon-sibleforthisstepparticipatedinatrainingsessiononhow

toapplytheinstrumentandallthestrategiesregardingthe

approach,explanationoftheresearchobjectivesand

instruc-tionstopatientswerediscussed.

Facevalidity

Thepre-testoftheBIFS-Pinthetargetpopulationwas

con-ductedin30primaryhealthcareusersofRibeirãoPretoina

singlehealthcarecliniclocatedinthecentralregion,which

catersfordifferentmedicalspecialties.Theincomprehension

index(proportion)ofeachitemwascalculatedand,if

neces-sary,theitemwasrewritten.

Datacollection

Thesamplewascomposedbyadultindividuals(≥18years),

residentsinRibeirãoPreto,southeasternBrazil,whoare

pri-maryhealth care users in the municipality. Ribeirão Preto

isamediumsizedcityofSãoPauloStatethathas

approxi-mately670,000inhabitants.Themunicipalityisdividedinto

five health districts,North, West, Central, Southand East.

Atthe timeof datacollection, there were 41 primary

gov-ernmenthealthcareclinicsinthemunicipality,whichwere

classifiedaccordingtothedistrictinwhichtheyarelocated

andtothePaulistaIndexofSocialVulnerability(PSVI)

preva-lentintheirarea.ThePSVIisdevelopedbytheSEADE(State

System ofData Analysis)from censusdata, with the

geo-graphicareasbeingclassifiedintosixdistinctgroupsofsocial

vulnerability.14Healthcareclinicsweregroupedinto12strata

accordingtothedistrictwheretheyarelocatedandthe

pre-dominantIPVS.TheclinicswherethePSVIwasequalto1or

2weregroupedinthesamestratumandtheclinicswithPSVI

equaltoorgreaterthan4weregroupedinanotherstratum.

Itshouldbenotedthatthisstudyispartofawiderproject

thataimstoevaluatetheassociationofsomevariableswith

blooddonation.Thus,thesamplesizewasobtained

consider-ingastratifiedsamplingplan,15a95%confidencelevelandan

absoluteprecisionof3%fortheestimativeoftheproportionof

blooddonors.Thisproportion,formaximizationofvariance,

wasconsideredequalto50%ineachstratum.Thus,a

sam-plesizeof1054interviewswasestimated,withthenumberof

interviewstobeconductedineachstratumbeingproportional

to their estimated population size. The healthcare clinics

wheretheinterviewswereconductedwereselectedrandomly

withineachstratum.InadditiontotheBIFS-P,aquestionnaire

aboutsociodemographiccharacteristicsandgeneralhealthof

theparticipantswasusedtocharacterizethesample.

PsychometricpropertiesofBIFS-P

FactorialvalidityoftheBIFS-Pwasassessedusingexploratory

factoranalysis(EFA)andconfirmatoryfactoranalysis(CFA).

EFA was performed using polychoric correlation methods

implementedusingtheSASsoftware.TheCFAwasalso

per-formedusingthepolychoriccorrelationsmatriximplemented

inthesoftware Mplus,version 6.0.Theestimation method

usedinCFAwastheweightedleastsquaresmeanand

vari-anceadjusted(WLSMV).TheratioofChi-squaretoitsdegrees

offreedom(2/df),comparativefitindex(CFI),Tucker–Lewis

index (TLI) and root mean square error of approximation

(RMSEA) were considered as goodness of fit indices. The

fit ofthe modelswasconsideredadequate when2/df was

≤2.0,CFIandTLIwas≥0.90and RMSEAwas<0.10.16 Items

with factor weights () lower than 0.40 were considered

underweightitemsforthecorrespondingfactor.Modification

indices,obtainedfromtheLagrangemultipliers,wereusedto

verifytheexistenceofcorrelationsbetweenerrors.16

Compar-isonsbetweenthetestedmodelswereperformedconsidering

their respectivefit ingeneral, through the goodness of fit

indices,withemphasisontheRMSEAindex.17 RMSEA

esti-matesshowhowwelltheparametersofthemodelreproduce

the population covariance and can be considered a

parsi-moniouscorrectionindex.Thus,lowervaluesofRMSEAare

indicativeofbettermodels.17,18

Factorial invariance of the models was assessed using

multigroup analysis considering the Chi-square difference

(2).Thisanalysis isused toevaluatethe stability ofthe

modelsindifferentsamples.Forthis,thetotalsamplewas

randomlydividedintotwoequalpartsthe‘testsample’and

the‘validationsample’.Inthisanalysistheequivalenceof

fac-torialweights[metricinvariance()],thefactorialweightsand

intercepts[scalarinvariance(Int)],andthefactorialweights,

interceptsandvariances/covariances[strictinvariance(Cov)]

wereevaluated.16,19

Ethicalaspects

ThisstudywasapprovedbytheEthicsCommitteeonHuman

ResearchoftheHospitaldasClínicasinRibeirãoPreto(CAAE:

38148814.2.0000.5440),withdatacollectionbeingapprovedby

theDepartmentofHealthofRibeirãoPreto.Inaddition,this

studywasconductedinaccordancewiththeHelsinki

Declara-tionasrevisedin2008.Onlyadultindividuals(≥18years)who

agreedandsignedinformedconsentformsparticipated.The

authors oftheoriginalscaleauthorizedthetranslation and

validationoftheinstrument.

Results

Contentvalidity

ThefirststepofthecontentvalidityprocessoftheBIFS-Pwas

performed byapaneloffourmale andfour female judges

withameanageof48.8(SD13.3)yearswhohavebeen

health-careprofessionalsfor20.6yearsonaverage(SD15.1).Ofthese,

37.5%workinhematology/transfusionmedicineservicesand

62.5%areengagedinprimaryhealthcareactivities.According

totheCVIvalues(CVI≥0.75forallitems),therewasnoneed

fornewtranslationsofanyitemoftheBIFS-P.However,some

importantsuggestionsweremadeandconsideredtosimplify

andadapttheinstrumentforthetargetpopulation.

Thesecondstepofthecontentvalidityprocesswas

per-formed by 20 judges, who did not participate in the first

stepofthisevaluation;80%werefemale,themeanagewas

(4)

Table1–OriginalandPortugueseversionofBlood/InjectionFearScaleandtheresultsofcontentvalidityratio(CVR)

estimatedforeachitem.

Item Portugueseversion Originalversion CVR

1 Eutenhomedodesentirdoraotomar

injec¸ão

I’mafraidofpainduetoreceiving injection

0.90

2 Eujátiveexperiênciasruinsaotomar

injec¸ão

I’vepreviousbadexperienceabout receivinginjection

0.20a

3 Euevitoolharaenfermeirapreparara seringadeinjec¸ão

Iavoidtowatchthenursepreparethe syringe

−0.30a

4 Eutenhomedodetomarinjec¸ão Iamafraidtoreceiveinjections 0.70 5 Eutenhomedodeveroutraspessoas

tomareminjec¸ão

Iamafraidtoseeothersreceiveinjections −0.30a

6 Euevitotomarinjec¸ão Iavoidreceivinginjections −0.20a 7 Otamanhodaagulhamedeixacommedo Needlesizefrightensme 0.40a 8 Eusintomal-estarquandotomoinjec¸ão IfeeldisgustedwhenIreceiveinjections 0.80 9 Eumeincomodocomapossibilidadede

veroutraspessoastomandoinjec¸ão

Iworryaboutthepossibilityofseeing othersreceiveinjections

−0.50a

10 Eumeincomodocomapossibilidadede terquetomarinjec¸ão

Iworryaboutthepossibilityofhavingto receiveinjections

0.40a

11 Eudesmaioquandotomoinjec¸ão IfaintafterIreceiveinjections 0.80 12 Eudesmaioquandovejooutraspessoas

tomandoinjec¸ão

IfaintwhenIseeothersreceiveinjections 0.00a

13 Euevitoverosanguedeoutraspessoas Iavoidseeingothers’blood 0.00a 14 Eumeincomodocomapossibilidadede

verosanguedeoutraspessoas

Iworryaboutthepossibilityofseeing others’blood

−0.50a

15 Eusintomal-estarquandovejomeu própriosangue

IfeeldisgustedwhenIseemyownblood 0.60

16 Euevitoolharparaomeuprópriosangue Iavoidlookingatmyownblood 0.30a 17 Eutenhomedodeolharparaomeu

própriosangue

Iamafraidofthesightofmyownblood 0.30a

18 Eudesmaioquandovejosangue IfaintwhenIseetheblood 0.60 19 Ocheirodasaladeaplicac¸ãome

incomoda

I’minfluencedbysmellsintheroom −0.30a

20 Eusintomal-estarquandovejoosangue deoutraspessoas

IfeeldisgustedwhenIseeothers’blood −0.20a

CVR:contentvalidityratio;CVR20;0.05=0.438. a Valuesbelowtheminimumsignificantvalue.

professionalsfor10.6(SD8.2)yearsonaverage.Ofthese,10%

areengagedinactivitiesofattendingthepopulationin

pri-maryhealthcareservices,10%arenursingstaffintransfusion

medicineorblooddonationservices,and80%areengagedin

othertypesofactivitiesinservicesofhematology/transfusion

medicineorblooddonation.Thecontentvalidityratio(CVR)

wasestimatedandispresentedinTable1.

OnlyItems1,4,8,11,15,and18wereconsideredessentials

bythejudges.

Facevalidity

Inthepre-testofthescaleinthetargetpopulation,30patients

wereinterviewed(female:73.3%;meanage:36.97±15.1years)

inasinglehealthcarecliniclocatedinthecentralregionofthe

municipalitywhichattendsdifferentspecialties.The

incom-prehensionindexwasnullforallitems,indicatingthatthere

wasnoneedforrewrites.

Psychometricproperties

Inthedatacollectionstepwhichaimstoevaluatethe

psy-chometric properties of the BIFS-P, 1055 users of primary

healthcareservicesinthemunicipalitywereinterviewedin

12 healthcare clinics (female: 79.7%;mean age: 40.6±15.2

years). Regarding the perception ofhealth, 69.7% classified

theirhealthas‘good’, 26.5%as‘regular’,and 3.8%as‘bad’.

Arterial hypertensionand diabetes mellituswere the most

prevalentchronicdiseasesinthesampleat22.0%and8.0%,

respectively.

Figure1presentsthepolychoriccorrelationsmatrixforthe

20itemsoftheBIFS-P.Highercorrelationcoefficients(>0.90)

weredetectedbetweenItems11and12,13and14,and16and

17.Items2and19werenotstronglycorrelatedwithanyother

itemoftheBIFS-P,withcorrelationcoefficientsbetween0.39

and0.62.

Table2showstheresultsoftheEFA.AccordingtotheEFA,

theitemscanbegroupedinuptofivefactors,withFactors4

and5beingresponsibleforprovidingamorespecificfeatureof

theBIFS-P.Thesefactorsarerelatedtofearand/orreactionson

seeingtheirownblood(Factor4)andtofearand/orreactions

toseeingthebloodofothers(Factor5).

Thus,threefactorialstructuresoftheBIFS-Pweretested

intheCFA:(1)originalfactorialstructurewithtwofirst-order

factors(fearofblood/fearofinjections);(2)factorialstructure

(5)

Items

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

0.9|-- 1.0 0.8|-- 0.9 0.7|-- 0.8 0.6|-- 0.7 0.5|-- 0.6 0.4|-- 0.5

Figure1–PolychoriccorrelationsmatrixfortheitemsofthePortugueseversionoftheBlood/InjectionFearScale.Darker colorswereattributedtohighercorrelationcoefficients.

Table2–Exploratoryfactoranalysis(EFA)performedfor

thePortugueseversionofBlood/InjectionFearScale

appliedtoasampleofprimaryhealthcareusersof

RibeirãoPreto,southeasternBrazil.

Items Factor1 Factor2 Factor3 Factor4 Factor5

1 0.94824 −0.04576 0.01594 0.01025 −0.05050

2 0.53484 0.03142 0.14454 0.03172 −0.00915

3 0.76520 0.13205 −0.08722 0.03735 0.05435

4 1.00683 −0.02188 0.02150 0.00254 −0.07423

5 0.40865 0.04349 0.06960 −0.01315 0.53536

6 0.76514 0.06143 0.10821 −0.04096 0.01040

7 0.85282 0.08602 −0.08119 0.04364 0.03388

8 0.53039 0.08319 0.32310 0.01095 0.07290

9 0.33508 0.02865 0.03671 0.00579 0.65536

10 0.81127 0.04275 0.09071 −0.01493 0.05383

11 0.13787 0.01650 0.94704 −0.06475 −0.04700

12 0.09631 0.01645 0.83284 −0.00927 0.08024

13 0.07872 0.96400 −0.04550 −0.03915 −0.03175

14 0.07691 0.96147 −0.00046 −0.07278 −0.00220

15 0.06794 0.48897 0.12326 0.48440 −0.04881

16 0.07099 0.45754 −0.00549 0.59339 0.00287

17 0.05699 0.48089 0.03722 0.52252 0.04549

18 −0.10038 0.41821 0.54167 0.17653 −0.03061

19 0.30834 0.33451 0.02683 0.09117 0.11449

20 −0.02867 0.83920 0.08419 0.07572 0.02694

Theshadingillustratesthegroupingofitemsaccordingtofactor.

factorialstructurewith5first-orderfactorsresultingfromEFA.

Thesestructuresare calledModel 1,Model2and Model3,

respectively.

Table3presents the resultsof theCFA forthe factorial

structurestestedfortheBIFS-P.Itshouldbementionedthat

itwasnecessarytoexcludeItem19duetoitslowfactorial

weightinallanalysesandlowercorrelationcoefficientswith

alltheotheritemsofthescaleinordertohaveadequatefits

ofallmodels(Figure1).

Despitetheappropriatefactorweightsofallitemsineach

factorinthethreemodelstested(>0.60),theoriginal

struc-turewithtwofactors(Model1)doesnotpresentanadequatefit

Table3–Factorialweights(),goodnessoffitindicesof

theconfirmatoryfactoranalysis(2/df,CFI,TLI,and

RMSEA),modificationindices,andcorrelationbetween

errorsadoptedforthethreefactorialstructurestested

forthePortugueseversionofBlood/InjectionFearScale

inasampleofprimaryhealthcareusersofRibeirão

Preto,southeasternBrazil.

Estimative Model1 Model2 Model3

0.65–0.95 0.66–0.99 0.67–0.99

2 2726.79 1294.88 989.64

2/df 18.94 9.25 7.50

CFI 0.97 0.99 0.99

TLI 0.97 0.98 0.99

RMSEA 0.13 0.09 0.08

RMSEA–95%CI 0.13–0.14 0.08–0.09 0.07–0.08

MI ≤546.13 ≤92.52 ≤63.00

CBE 7.00 8.00 10.00

CFI:comparativefitindex;TLI:Tucker–Lewisindex;RMSEA:root meansquareerrorofapproximation;95%CI:95%confidence inter-val; MI: modification indices; CBE: correlations between errors considered.

Model1:originalstructureconsideringtwofirst-orderfactors. Model2:Structurewiththreefactorsobtainedinexploratoryfactor analysis.

Model3:Structurewithfivefactorsobtainedinexploratoryfactor analysis.

tothedataconsideringthegoodnessoffitindices.Evenafter theexclusionofItem19andthemodelre-specification(seven correlations betweenerrorsconsidered),Model 1presented resultsofRMSEAhigherthanadequateandhighmodification indices,whichcanbeconsideredapooradjustment(Table3).

Ontheotherhand,Models2and3presentedadequatefitto

thedata,withgoodnessoffitindiceswithinacceptablelimits

(afterre-specificationofthemodelsandtheexclusionofItem

19).Despitehighlevelsof2/df,thisindexisoverestimated

inlargersamples,andshouldbeevaluatedtogetherwiththe

(6)

Structure with three factors (Model 2)

Structure with five factors (Model 3)

1 1 2 3 4 6 7 8 10 5 9 11 12 13 14 18 20 15 16 17 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 20 FIG FFI FBG FOB FBO FFI FORI FRI .86 .67 .85 .92 .86 .89 .87 .94 .94 .93 .98 .99 .90 .92 .78 .94 .94 .95 .96 .88 .67 .68 .68 .67 .67 .68 .88 .71 .59 .73 .73 .67 .96 .93 .84 .88 .89 .86 .85 .92 .84 .66 .85 .99 .81 .84 .95 .93 .94 .82 .85

Figure2–DistributionofitemsofthePortugueseversionofBlood/InjectionFearScaleineachfactorandthelocalfit()of Models2and3ofthedataobtainedintheconfirmatoryfactoranalysis.FIG:fearofinjectioningeneral;FFI:faintingdueto fearofinjection;FBG:fearofbloodingeneral;FRI:fearofreceivinginjection;FORI:fearofseeingothersreceivinginjection; FFI:faintingduetofearofinjection;FBO:fearofseeingbloodofothers;FOB:fearofownblood.

Models2and3,observingtheRMSEAvaluesandtheir

con-fidenceintervals,itisclearthatnomodelhasabetterfitas

bothmodelsareproperlyadjustedtothedataandboth

struc-turescanbeconsideredintheassessmentoffearofbloodand

injectionsinthissample.

Distributionoftheitemsineachfactorconsideredinthe

confirmatoryfactoranalysisofModels2and3andthefactorial

weights()arepresentedinFigure2.Thenamesofthefactors

wereadoptedinaccordancewiththetheoreticalcontentof

theitemswhengrouped.

All items presented adequate factorial weights for the

correspondingfactors(≥0.66),whichconfirmsanadequate

distributionofitemsintheexploratoryfactoranalysis.

Model 2 (structure with three factors) presented

equiv-alenceoffactorial weights(metric invariance –: 2=18.7;

p-value=0.29), of factorial weights and intercepts (scalar

invariance – Int: 2=85.2; p-value=0.10), and of factorial

weights,interceptsand variances/covariances(strict

invari-ance–Cov:2=67.7;p-value=0.09)consideredverystablein

differentsamples.Model3(structure withfivefactors)

pre-sentedequivalenceoffactorialweightsindifferentsamples

(metricinvariance–:2=20.6;p-value=0.11)withpoor

sta-bility.

Discussion

There is a lack of studies and instruments to assess

blood/injection phobia in the general Brazilian population,

sincemostoftheinstrumentsavailablearespecificto

psychi-atryandfocusondiagnosisandtreatment.Inaddition,little

isknownabouttheprevalenceofthistypeofphobiaand

asso-ciatedfactorsintheBrazilianpopulation;thisisanimportant

gapinthescientificliteratureinthefaceoftheimportant

con-sequencesthatfearofbloodandinjectionmayhaveonthe

individual’shealth.

RegardingtheCVRestimatedfortheitems,onlysixitems

were considered essentialbythe judges (Table1).Ofthese

items,fourarerelatedtothefearofreceivinginjectionsand

adversereactionsandtwoarerelatedtothereactionssuchas

discomfort/feelingillonseeingtheirownbloodand/or

faint-ing atthesightofblood.As90.0% ofthejudges arehealth

professionals who performsomekind ofactivity in

hema-tology/transfusion medicine/blood donation services, these

results suggest that there may have been a trend by the

professionalsongivemoreimportancetotheseitems.

(7)

considered as a complementary analysis and may not be

used onlyas justification forthe exclusion ofitems of an

instrument.20,21

Inthepolychoriccorrelationsmatrixpresented(Figure1),

mostitemsoftheBIFS-Pwerestronglycorrelatedaccording

toparticipants’responses.Despitethehighcorrelation

coef-ficient(>0.90)betweenthreepairsofitems(11and12,13and

14,and16and17),theseitemsshowedhighfactorweightsin

allthemodelstestedintheCFA(Figure2)andforthisreason

theyhavebeenmaintainedintheinstrument.However,this

isnotthecaseofItem19,relatedtothesmellofthe

injec-tionapplicationroom.Thisitem,besidesthelowcorrelation

withallotheritemsofthescale(Figure1),presentedlow

fac-torweightinallmodelstested,andhinderedtheirfit.Forthis

reason,weoptedtoexcludeItem19intheanalysis,andthis

exclusionwasguidedbothbythelowfactorialweightdetected

andbytheclassificationasanon-essentialiteminthecontent

analysis.

Thechoice ofthe best factorial structureto beused to

assessthefearofblood/injectionsinthegeneralpopulation

isworthsomeconsideration.Firstly,bothmodels(withthree

andfivefactors)presentedadequatefittothedata,

suggest-ingthatbotharesuitabletomeasuretheconstruct.However,

Model2providesamorecomprehensivemeasureguidedby

alargergroupingofitems.Model3,inturn,providesamore

specificmeasure,whichcandistinguishmorepreciselythe

situationoffearandreactions.Thus,thechoiceofthe

struc-turetobeusedwilldependontheobjectivesofeachstudyto

beconducted.Furthermore,Model2wasstronglystableinthe

analysisoffactorialinvarianceinrandomsubsamples,which

allowsustosuggest itsuse instudies ofBrazilianusers of

healthcareservices.

WithrespecttotheoverallscoreoftheBIFS-P,theauthorsof

theoriginalproposalsuggestthesumofallanswers.However,

therearestrongargumentsthatcontradicttheuseofthesum

ofresponseswhenusingpsychometricscalesmainlydirected

atthedifferentfactorialweightsofitemsanddistributionof

factorsindistinctpopulations.20,21Thus,wesuggestusingthe

arithmeticmeanforthecomputationofanoverallscoreora

scoreforeachfactorseparately.

WeconcludethattheBIFS-Pisanimportantinstrument

inthefaceofadequatepsychometricpropertiesfoundinthe

sampleofprimaryhealthcareusers andits simplicityand

easeofunderstandingwithinthepublichealthcontext.We

suggestthatotherstudiesshouldbeconductedtoassessthe

psychometric properties ofthe BIFS-P in different

popula-tions such aspatients with chronic disease,blood donors,

elderly people, high school students, students in

health-carecourses,amongothers,aimingtoexpandtheutilityof

this instrument and contributeto other areas ofcollective

health.

Financial

support

This study was supported by the Fundac¸ão de Amparo

à Pesquisa do Estado de São Paulo (FAPESP) under grant

#2014/14020-6;andtheCoordenac¸ãodeAperfeic¸oamentode

PessoaldeNívelSuperior(CAPES).

Conflicts

of

interest

Theauthorsdeclarenoconflictsofinterest.

Acknowledgements

This study was funded by the Fundac¸ão de Amparo à

PesquisadoEstadodeSãoPaulo(FAPESP)2014/14020-6andthe

Coordenac¸ãodeAperfeic¸oamentodePessoaldeNívelSuperior

(CAPES).

r

e

f

e

r

e

n

c

e

s

1.HagopianLP,CrockettJL,KeeneyKM.Multicomponent treatmentforblood-injury-injectionphobiainayoungman withmentalretardation.ResDevDisabil.2001;21(2):141–9.

2.KoseS,MandiraciogluA.Fearofblood/injectioninhealthy andunhealthyadultsadmittedtoateachinghospital.IntJ ClinPract.2007;61(3):453–7.

3.TrijsburgRW,JelicicM,VandenBroekWW,PlekkerAEM, VerheijR,PasschierJ.Exposureandparticipantmodellingina caseofinjectionphobia.PsychotherPsychosom.

1996;65(1):57–61.

4.BuodoG,SarloM,PoliS,GiadaF,MadalossoM,RossiC,etal. Emotionalanticipationratherthanprocessingisalteredin patientswithvasovagalsyncope.ClinNeurophysiol. 2012;123(7):1319–27.

5.ArmstrongT,HemmingerA,OlatunjiBO.Attentionalbiasin injectionphobia:overtcomponents,timecourse,andrelation tobehavior.BehavResTher.2013;51(6):266–73.

6.MiloyanB,EatonWW.Blood-injection-injuryphobiainolder adults.IntPsychogeriatr.2016;28(6):897–902.

7.PageAC,BennettKS,CarterO,SmithJ,WoodmoreK.The Blood-InjectionsSymptomScale(BISS):assessingastructure ofphobicsymptomselicitedbybloodandinjections.Behav ResTher.1997;35(5):457–64.

8.D’ElReyGJ,PaciniCA.Prevalênciadafobiade

sangue-injec¸ão-ferimentosemamostradapopulac¸ãodeSão Paulo-SP.PsicolArgum.2005;23(43):53–9.

9.D’ElReyGJ,PeroniPC.Estudodeconfiabilidadedaversãoem portuguêsdaEscaladeSintomasdeSangue-Injec¸ão(BISS). Psicologia.2007;12(11):1–11.

10.GuimarãesAM,SilvaNetoAC,VilarAT,AlmeidaBG, AlbuquerqueCM,FermoseliAF.Transtornosdeansiedade: umestudodeprevalênciasobreasfobiasespecíficasea importânciadaajudadapsicologia.CadGrad.

2015;3(1):115–28.

11.PolitDF,BeckCT.TheContentValidityIndex:areyousureyou knowwhat’sbeingreported?Critiqueandrecommendations. ResNursHealth.2006;29(5):489–97.

12.LawsheCH.Aquantitativeapproachtocontentvalidity.Pers Psychol.1975;28(4):563–75.

13.WilsonFR,PanW,SchumskyDA.Recalculationofthecritical valuesforLawshe’scontentvalidityratio.MeasEvalCouns Dev.2012;45(3):197–210.

14.FerreiraMP,DiniNP,FerreiraSP.Espac¸osedimensõesda pobrezanosMunicípiosdoEstadodeSãoPaulo:Índice PaulistadeVulnerabilidadeSocial–IPVS.SãoPauloPerspect. 2006;20(1):5–17.

15.ScheafferRL,MendenhallW,OttRL,GerowK.Elementary SurveySampling.7thed.Boston:CengageLearning;2011.

(8)

17.LeónDA.AnáliseFatorialConfirmatóriaatravésdos SoftwaresReMplus.PortoAlegre,Brazil:Universidade FederaldoRioGrandedoSul;2011.

18.KlineRB.Principlesandpracticeofstructuralequation modeling.NewYork:TheGuilfordPress;1998, 354pp.

19.KaplanD.Structuralequationmodeling:foundationsand extensions.ThousandOaks,CA:SagePublications;2000.

20.AnastasiA.Psychologicaltesting.6thed.NewYork: MacmillanPublishingCompany;1988.

Imagem

Table 1 – Original and Portuguese version of Blood/Injection Fear Scale and the results of content validity ratio (CVR) estimated for each item.
Figure 1 – Polychoric correlations matrix for the items of the Portuguese version of the Blood/Injection Fear Scale
Figure 2 – Distribution of items of the Portuguese version of Blood/Injection Fear Scale in each factor and the local fit (  ) of Models 2 and 3 of the data obtained in the confirmatory factor analysis

Referências

Documentos relacionados

The molecular response profile of patients with samples in all time intervals ( n = 82) showed in the first interval (three to five months) that 78.1% (64/82) had 1 log reduction in

An Excel spreadsheet was sent to all participating insti- tutions, who were asked to provide the following data: patient’s initials; gender; histologic subtype; date of birth; date

Table 2 – Prevalence of chronic medical conditions in patients with and without iron deficiency anemia in elderly subjects aged 60 years and more. Chronic medical conditions

Know- ing the human leukocyte antigens allele group and haplotype frequencies as well as the linkage disequilibrium between alleles of different human leukocyte antigens loci

The objective of this study was to compare miRNA expression profiles of patients with Binet A chronic lymphocytic leukemia with those of sub- jects with high-count monoclonal

Results: The cases included were 78 chronic lymphocytic leukemias, three atypical chronic lymphocytic leukemias, six marginal zone lymphomas, 11 splenic marginal zone lym- phomas,

Thrombin generated in the thrombin generation test can be quantified as platelet-rich or platelet-poor plasma using the calibrated automated thrombogram method, which monitors

Nutritional assessment and serum zinc and copper concentration in leukemic children. Garófolo A, Lopez FA,